We source our biosimilars and breakthrough medicines from leading manufacturers around the world and deliver them where they are needed.
We develop a close partnership with healthcare professionals, supporting them in their work by giving them the reliable service they need.
We contribute to a more efficient health care system by improving services and reducing costs.
Laurent Massuyeau, iQone Executive Chairman & Founder
We source from some of the world's leading drug manufacturers, bringing state-of-the-art therapeutics directly to the Swiss market.
We've been serving rheumatologists and gastro-enterologists in Switzerland for more than five years, keeping a constant eye out for the next generation of therapeutic options, whether from biosimilars or orphan drugs ‒ or other breakthrough medicines.
Our portfolio of products for oncology treatments is one of the strongest in Switzerland and will continue to grow. Now our plan is to replicate that position with innovative medicines for targeted cancers.
The newest passion of our company is finding top quality treatments for rare diseases and introducing these as quickly as possible in our markets. With a team experienced in the approval, launch and support of orphan drugs, this may be our latest focus but far from anything new to us.
Our goal is to become one of Switzerland's leading providers of therapeutic advances including biosimilars and biobetters. But we can't do that alone. It starts with a superior portfolio of products, sourced from best-in-class partners like Celltrion Healthcare. Celltrion is a global pharmaceutical company committed to delivering advanced ‒ yet affordable ‒ therapeutics to patients and physicians. We are Celltrion's main distributor in Switzerland; other manufacturers turn to us too, and our pipeline is continually growing.
Our partnerships also include the associations and working groups we're active in, like biosimilar.ch, to promote the benefits of biosimilars. And we partner with the many hospitals and medical practices that have put their trust in the iQone name.
“What l like at iQone is that we are customer-centric and very open to creative approaches to addressing business needs. Unlike large companies in the sector, we focus on the bigger picture, and we are always open to medical advances and progress.”
“I’m happy and proud to be part of a very solid and experienced sales force at iQone. Thanks to our pragmatism, entrepreneurial mindset and fast decision-making capabilities, we have all the tools we need to perform our jobs in the best possible environment.”
“It is really empowering for all of us to be working on such a qualified and experienced team. We combine the agility, open-mindedness and daring of a small firm with the rigor and fundamental values of big pharma companies.”